Les incontournables

• Calcium Channel Blockade Versus beta-Blockade for Hypertension in Heart Failure With Preserved Ejection Fraction: A Randomized Crossover Trial. Hypertension. 2026 Jul;83(7):e26801. Lire
• 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2026 Jul 28;154(4):e50-e158. Lire
• 2026 ISH guidelines for the management of hypertension in Africa: the International Society of Hypertension (ISH) African Regional Advisory Group and the Pan African Society of Cardiology (PASCAR). J Hypertens. 2026 Oct 1;44(10):1732-1760. Lire
• Single Interventions (Pharmacological or Renal Denervation) Are Not Sufficient to Achieve Blood Pressure Control in Resistant Hypertension: A Systematic Review and Meta-Analysis. Hypertension. 2026 Aug;83(8):e26756. Lire
• Mineralocorticoid receptor antagonists and mortality in hypertension: a systematic review and meta-analysis. J Hypertens. 2026 Jul 1;44(7):1238-1246 Lire

Articles

• Article sur la Dépêche Vétérinaire : Santé cardiovasculaire des femmes au travail : mieux prévenir et mieux dépister Lire
• Article sur la Semaine Vétérinaire : Appel aux consoeurs à prendre soin de leur Coeur Lire
• ISH e-Bulletin aout 2026 : Lire
• ESH Newsletter (Summer School 2026), Lire

Essais cliniques

• Calcium Channel Blockade Versus beta-Blockade for Hypertension in Heart Failure With Preserved Ejection Fraction: A Randomized Crossover Trial. Hypertension. 2026 Jul;83(7):e26801, Lire

Méta-analyses

• Single Interventions (Pharmacological or Renal Denervation) Are Not Sufficient to Achieve Blood Pressure Control in Resistant Hypertension a Systematic Review and Meta-Analysis. Hypertension. 2026, Lire
• Adverse Effects and Treatment Discontinuation of Blood Pressure-Lowering Drugs and Combinations: A Network Meta-Analysis. JAMA. 2026 Jun 23;335(24):2135-2145, Lire

Epidémiologie

• Blood Levels of Angiotensinogen and Risk of Ischemic Stroke: The Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc. 2026 Jun 16;15(12):e047698, Lire
• Blood Pressure Variability and Outcomes Across Antihypertensive Regimens. Hypertension. 2026 Jun 25, Lire
• Orthostatic Blood Pressure, Cardiovascular Disease, and Hypotensive Events. Hypertension. 2026 Jul;83(7):e25773, Lire

Revues

• Hypertension at an Inflection Point: Aggressive Targets Meet Novel Mechanisms for Cardiovascular Prevention. J Am Coll Cardiol. 2026 Jun 5:S0735-1097(26)064892. Lire
• Empowering Patients and Clinicians: LLMs in Hypertension Care, A Scoping Review. Hypertension. 2026 Jul;83(7):e27004, Lire

Articles

• Article sur la Dépêche Vétérinaire : Santé cardiovasculaire des femmes au travail : mieux prévenir et mieux dépister Lire
• Article sur la Semaine Vétérinaire : Appel aux consoeurs à prendre soin de leur Coeur Lire
• ISH e-Bulletin juin 2026 : Lire
• WHL Newsletter juin 2026, Lire

Essais cliniques

• Efficacy of Tonlamarsen in Patients With Uncontrolled Hypertension: The KARDINAL Phase 2 Randomized Clinical Trial. JACC. 2026 May 12;87(18):2508-2520. Lire
• Frailty Index Offers Greater Discrimination Than Age for Optimal Blood Pressure Targets: A Pooled Analysis of Two Randomized Trials. Hypertension. 2026 Jun;83(6):e26397. Lire

Cohortes

• Renin-Aldosterone Profiles and Cardiorenal Outcomes in Hypertension: A Nationwide Cohort Study. JACC. 2026 May 26;87(20):2846-2860. Lire

Enquêtes

• Barriers for Secondary Hypertension Screening in the United States: A National Physician Survey. J Am Heart Assoc. 2026 Jun 2;15(11):e049858. Lire

Revues

• Environmental risk factors and cardiovascular health. Eur Heart J. 2026 May 7:ehag270. Lire

Articles

• Article sur la Dépêche Vétérinaire : Santé cardiovasculaire des femmes au travail : mieux prévenir et mieux dépister Lire
• Article sur la Semaine Vétérinaire : Appel aux consoeurs à prendre soin de leur Coeur Lire
• ISH e-Bulletin mai 2026 : Lire

Essais cliniques

• Multifaceted Strategies for Hypertension Control in Low-Income Patients. Mills KT, et al.N Engl J Med. 2026 Apr 9;394(14):1376-1387 Lire
• Effect of baxdrostat on ambulatory blood pressure in patients with resistant hypertension (Bax24): a phase 3, randomised, double-blind, placebo-controlled trial. Azizi M, et al; Bax24 investigators. Lancet. 2026 Mar 7;407(10532):988-999 Lire

Etudes observationnelles

• Impact of a Smartwatch Hypertension Notification Feature for Population Screening. Cohen JB, et al. JAMA. 2026 Mar 17;335(11):1001-1003 Lire

Revues

• Blood pressure lowering in isolated diastolic hypertension and cardiovascular risk: an individual patient data meta-analysis. Bidel Z, et al; Blood Pressure Lowering Treatment Trialists’ Collaboration Eur Heart J. 2026 Apr 7;47(14):1649-1657 Lire
• New drug therapies for hypertension. Azizi M, et al. Lancet. 2026 Mar 7;407(10532):1014-1028 Lire
• Practical approach to evaluate and manage hypertension in youth: an International Society of Hypertension position paper. Flynn JT, et al. J Hypertens. 2026 Apr 1;44(4):553-571 Lire

Articles

• Article sur la Dépêche Vétérinaire : Santé cardiovasculaire des femmes au travail : mieux prévenir et mieux dépister Lire
• Article sur la Semaine Vétérinaire : Appel aux consoeurs à prendre soin de leur Coeur Lire
• ISH e-Bulletin mars 2026 : Lire

Essais cliniques

• Pharmacogenomics-guided personalized therapy for hypertension: a multicenter randomized trial.Yu M, et al.J Hypertens. 2026 Feb 16 Lire

• Adherence to Different Dietary Patterns and Subsequent Risk of Total, Ischemic, and Hemorrhagic Stroke.Castro-Barquero S, et al.Stroke. 2026 Feb 23 Lire

• mHealth Intervention to Improve Hypertension Care in High-Risk Patients. Lakshminarayan K, et al.Hypertension. 2026 Feb 20 Lire

Revues

• Blood-Pressure Targets in Hypertension Management. Kotanidis CP, et al.N Engl J Med. 2026 Mar 5;394(10):1026-1029 Lire 

• New drug therapies for hypertension. Azizi M, et al. Lancet. 2026 Feb 10 Lire

• Broadening Primary Aldosteronism Screening: Alignment Across Contemporary Guidelines. Owei L, et al. Hypertension. 2026 Feb 6 Lire 

• Practical approach to evaluate and manage hypertension in youth: an International Society of Hypertension position paper. Flynn JT, et al. J Hypertens. 2026 Apr 1;44(4):553-571 Lire

• Forecasting the Burden of Cardiovascular Disease and Stroke in Women in the United States Through 2050: A Scientific Statement From the American Heart Association. Joynt Maddox KE, et al. Circulation. 2026 Feb 25 Lire 

• Single-Pill Combination Therapy for the Management of Hypertension: A Scientific Statement From the American Heart Association. King JB, et al. Hypertension. 2026 Mar;83(3):e00258 Lire 

• Cuffless Devices for the Measurement of Blood Pressure: A Scientific Statement From the American Heart Association. Cohen JB, et al. Hypertension. 2026 Mar;83(3):e00254 Lire

Cohortes

• Big Data Approach to Assessment of an Aldosterone-Renin Ratio for Detection of Potential Surgical Cases of Primary Aldosteronism.Leung AA, ey al. Hypertension. 2026 Mar 4 Lire 

• Association Between 24-Hour Systolic Blood Pressure Time in Target Range and Mortality. Lauder L, et al. Hypertension. 2026 Feb 27 Lire 

• From French Gastronomy to Cardiovascular Health: Cutting Salt in the Baguette Has Saved Thousands of Lives in France. Grave C, et al. Hypertension. 2026 Mar;83(3):e25977 Lire

• ISH e-Bulletin février 2026 : Lire

Santé mondiale et recommandations

• WHO global report on hypertension 2025..Farrar J, Frieden T. Lancet. 2025 Nov 15;406(10517):2318-2319. Lire
• Global, regional, and national burden of chronic kidney disease in adults, 1990-2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023. GBD 2023 Chronic Kidney Disease Collaborators. Lancet. 2025 Nov 7:S0140-6736(25)01853-7. Lire
• Role of Circadian Health in Cardiometabolic Health and Disease Risk: A Scientific Statement From the American Heart Association.Knutson KL, et al. Circulation. 2025 Oct 28. Lire

Revues

• Renal Histology Findings in Malignant Hypertension, a Systematic Review. Maisons V, et al.Hypertension. 2025 Nov 4. Lire

Etudes de cohorte

• Blood pressure variability is associated with heart failure risk, elevated NT-proBNP, and elevated high-sensitivity troponin: the Multi-Ethnic Study of Atherosclerosis (MESA). Nuyujukian DS, et al. Am J Hypertens. 2025 Nov 14:hpaf226. Lire
• Hypertension in Young Adults: Social Determinants of Prevalence, Awareness, Treatment, and Control. Alexander TJ, et al. Am J Hypertens. 2025 Nov 13:hpaf203. Lire
• Renal Denervation in Patients With Moderate to Severe Chronic Kidney Disease. Schlaich MP, et al. Hypertension. 2025 Oct 29. Lire

Post-Hoc de l’étude SPRINT

• Relationship Between Home Blood Pressure Monitoring-Confirmed Resistant Hypertension and Cardiovascular Prognosis Kario K, et al. Hypertension. 2025 Oct 23. Lire
• Effect of Intensive Systolic Blood Pressure Control on Markers of Cerebral Small Vessel Disease by Age.Pruzin JJ, et al. Hypertension. 2025 Oct 29. Lire

Essais cliniques

• DASH-Patterned Groceries and Effects on Blood Pressure: The GoFresh Randomized Clinical Trial.Juraschek SP, et al.JAMA. 2025 Nov 9:e2521112. Lire

Recherche Fondamentale

• Identification and Characterization of Alamandine-(1-5), a New Component of the Renin-Angiotensin System. Santos RAS, et al. Circ Res. 2025 Nov 12. Lire

Clinical trials

• Efficacy of olive leaf extracts in controlling blood pressure in hypertensive patients: a double-blind randomized clinical trial.Lamti F, et al.J Hypertens. 2025 Nov 1;43(11):1878-1884. doi: 10.1097/HJH.0000000000004141 LIRE
• Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension. Flack JM, Azizi M, et al; BaxHTN Investigators. N Engl J Med. 2025 Oct 9;393(14):1363- 1374. doi: 10.1056/NEJMoa2507109 LIRE

Revues

• Benefit-harm trade-offs of intensive blood pressure control versus standard blood pressure control on cardiovascular and renal outcomes: an individual participant data analysis of randomised controlled trials.Guo X, et al; BPRULE Study Group.Lancet. 2025 Sep 6;406(10507):1009-1019. doi: 10.1016/S0140-6736(25)01391-1. LIRE
• Overcoming Barriers to Developing and Implementing Novel Therapies for Hypertension. Krychtiuk KA, et al. Hypertension. 2025 Oct;82(10):1599-1611. doi: 10.1161/HYPERTENSIONAHA.125.24992. LIRE
• Clinical staging to guide management of metabolic disorders and their sequelae: a European Atherosclerosis Society consensus statement. Romeo S, et al; European Atherosclerosis Society Consensus. Eur Heart J. 2025 Oct 7;46(38):3685-3713. doi:10.1093/eurheartj/ehaf314. LIRE
• Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline. Adler GK,et al. J Clin Endocrinol Metab. 2025 Aug 7;110(9):2453-2495. doi: 10.1210/clinem/dgaf284 LIRE

Post-hoc analyses of clinical trials

• Effects of Intensive Blood Pressure Control in Patients With Frailty: A Post Hoc Analysis From ESPRIT. Li S, et al; ESPRIT Investigators. J Am Coll Cardiol. 2025 Oct 15:S0735-1097(25)07783-6. doi: 10.1016/j.jacc.2025.08.092. LIRE
• Systolic Blood Pressure Time in Target Range and Acute Kidney Injury in Patients With Hypertension. Chen WH, et al. Hypertension. 2025 Oct 9. doi: 10.1161/HYPERTENSIONAHA.125.25511. LIRE

Etudes observationnelles

• Contemporary Burden of Cardiovascular Disease in Pregnancy: Insights From a Real-World Pregnancy Electronic Health Record Cohort. Lau ES, et al. Circulation. 2025 Oct 14;152(15):1044-1055. doi: 10.1161/CIRCULATIONAHA.125.074692. LIRE
• Shiny and Mobile Apps for Estimating Blood Pressure Percentiles in Children. Montelisciani L, et al. Hypertension. 2025 Oct 1. doi: 10.1161/HYPERTENSIONAHA.125.25087. LIRE
• Prescription Trends of Hydrochlorothiazide vs. Chlorthalidone in the United States (2019-2024). Asante R, et al. Am J Hypertens. 2025 Sep 23:hpaf190. doi: 10.1093/ajh/hpaf190. LIRE
• Poor Accuracy of Blood Pressure Measurement Images Online: Implications for Public Health Education. Aminde LN, et al. Hypertension. 2025 Sep 8. doi: 10.1161/HYPERTENSIONAHA.125.25064 LIRE
• Association Between Migraine and Hypertension in 2 Million Adolescents. Akavian I, et al. Hypertension. 2025 Sep 4. doi: 10.1161/HYPERTENSIONAHA.125.24861. LIRE